# PhosChol (Phosphatidylcholine)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/phoschol
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-01
**Evidence Score:** 2 / 10
**Category:** Other
**Also Known As:** Phosphatidylcholine, PC, Lecithin phosphatidylcholine, Polyunsaturated phosphatidylcholine, PPC, Essential phospholipids, Soy phosphatidylcholine, 1,2-diacyl-sn-glycero-3-phosphocholine

## Overview

PhosChol is a highly purified phosphatidylcholine (PC) concentrate derived from soy lecithin, providing the bioactive phospholipid that forms the structural backbone of cell membranes and bile. It supports liver and gut health primarily by restoring phospholipid composition in hepatocyte membranes and reinforcing the intestinal mucus layer via PC-enriched mucus secretion.

## Health Benefits

• Ulcerative colitis support: Phase 2 RCT showed 50% of patients achieved steroid withdrawal vs 10% placebo (moderate evidence)
• [Liver health](/ingredients/condition/detox) in NAFLD: Observational study of 2,843 patients showed 68.3% improved liver echogenicity at 24 weeks (preliminary evidence)
• [Gut barrier](/ingredients/condition/gut-health) protection: May strengthen mucosal barrier by integrating into mucus phospholipids (preliminary evidence)
• Steroid-sparing effect: 80% of UC patients discontinued steroids without flare vs 10% placebo in one trial (moderate evidence)
• Hepatocyte protection: Polish RCT showed 26.7% histological improvement in NAFLD patients vs 7.1% placebo (preliminary evidence)

## Mechanism of Action

Phosphatidylcholine is incorporated into hepatocyte plasma membranes via the CDP-choline (Kennedy) pathway, restoring membrane fluidity and reducing [lipid peroxidation](/ingredients/condition/antioxidant) by serving as a substrate for phospholipase A2-mediated arachidonic acid release modulation. In the intestinal tract, PC is secreted into the mucus gel layer by goblet cells, where it forms a hydrophobic barrier that limits bacterial translocation and reduces NFκB-driven mucosal [inflammation](/ingredients/condition/inflammation). PC also donates choline for betaine synthesis via choline oxidase, supporting hepatic methionine [metabolism](/ingredients/condition/weight-management) and SAM-dependent methylation reactions critical for VLDL assembly and fat export from the liver.

## Clinical Summary

A Phase 2 randomized controlled trial in ulcerative colitis patients demonstrated that delayed-release phosphatidylcholine achieved steroid withdrawal in 50% of participants versus 10% in the placebo group, representing moderate-quality evidence. A large observational study of 2,843 NAFLD patients treated with polyenylphosphatidylcholine reported improved liver echogenicity (a sonographic marker of hepatic fat) in 68.3% of subjects at 24 weeks, though the absence of randomization limits causal inference. Preclinical and early human data suggest PC supplementation strengthens [gut barrier](/ingredients/condition/gut-health) function by enriching the colonic mucus phospholipid content, reducing bacterial endotoxin translocation, but large RCTs in this application are lacking. Overall, evidence is strongest for ulcerative colitis and promising but preliminary for NAFLD and gut permeability.

## Nutritional Profile

PhosChol is a highly purified phosphatidylcholine (PC) concentrate derived from soy lecithin, standardized to contain approximately 900mg of polyenylphosphatidylcholine (PPC) per softgel (standard dose). Primary bioactive compound: phosphatidylcholine (≥99% purity in PhosChol Concentrate), composed of glycerophosphocholine backbone esterified with predominantly polyunsaturated fatty acids — linoleic acid (omega-6, ~50-60% of fatty acid composition) and other polyunsaturated fatty acids. Choline content: approximately 250-400mg elemental choline equivalent per 900mg PC dose, contributing to dietary choline intake (AI: 425-550mg/day for adults). Lipid composition: phospholipid class constitutes ~100% of active fraction, with negligible triglycerides, cholesterol, or other lipid fractions due to purification process. No significant protein, carbohydrate, or dietary fiber content. Micronutrients: trace amounts only — not a meaningful source of vitamins or minerals. Bioavailability notes: phosphatidylcholine is hydrolyzed in the small intestine by phospholipase A2 to lysophosphatidylcholine (LPC), which is the primary absorbed form via intestinal epithelial cells; LPC is re-acylated back to PC in enterocytes and incorporated into chylomicrons for lymphatic transport. A portion of choline moiety is metabolized by gut microbiota to trimethylamine (TMA), subsequently oxidized to TMAO in the liver — relevant for [cardiovascular](/ingredients/condition/heart-health) considerations. The polyunsaturated fatty acid profile distinguishes PPC from saturated PC forms, conferring membrane-fluidizing properties and mucosal integration capacity. Caloric contribution: approximately 8-10 kcal per 900mg softgel (primarily from fatty acid chains).

## Dosage & Preparation

Ulcerative colitis: 2-3.2 g/day (divided into 4 doses). NAFLD/NASH: 1.368-2.1 g/day (typically 600-700 mg three times daily). Forms include standard PC powder and delayed-release formulations. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

PhosChol is generally well tolerated at typical doses of 900–1,800 mg PC daily; the most common side effects are mild gastrointestinal complaints including nausea, loose stools, and increased salivation, which are dose-dependent. Gut microbiota (specifically TMA lyase-expressing bacteria) can metabolize the choline moiety of PC to trimethylamine (TMA), which is hepatically oxidized to TMAO, a compound associated with [cardiovascular risk](/ingredients/condition/heart-health) at chronically elevated levels — a consideration for individuals with dysbiosis or high cardiovascular baseline risk. PC may theoretically potentiate cholinergic drugs (e.g., [acetylcholine](/ingredients/condition/cognitive)sterase inhibitors such as donepezil) by increasing acetylcholine substrate availability, warranting caution in patients on these medications. Safety data in pregnancy are limited; while dietary choline is essential during pregnancy, supplemental high-dose PC should only be used under medical supervision in pregnant or breastfeeding individuals.

## Scientific Research

Key trials include a phase 2 RCT (PMID: 17975182) showing efficacy in 60 steroid-refractory UC patients, though a larger phase 3 trial (PMID: 37806372) was terminated early for futility. A large observational study (PMC7011021) in 2,843 NAFLD patients demonstrated improvements in liver echogenicity, supported by smaller RCTs showing histological benefits.

## Historical & Cultural Context

No traditional medicine use was documented in the research. Modern therapeutic applications emerged post-2000s, derived from lecithin research since the mid-20th century for liver support, without specific ties to traditional medicine systems.

## Synergistic Combinations

Milk thistle, Alpha-lipoic acid, N-acetylcysteine, Vitamin E, Curcumin

## Frequently Asked Questions

### What is the difference between PhosChol and regular lecithin supplements?

Standard soy lecithin typically contains only 20–30% phosphatidylcholine by weight alongside other phospholipids, whereas PhosChol is a purified concentrate standardized to approximately 900 mg of polyenylphosphatidylcholine (PPC) per softgel, delivering a therapeutically relevant dose in fewer capsules. This higher purity means PhosChol provides more linoleic acid-rich PC species (specifically 1,2-dilinoleoylphosphatidylcholine) that are preferentially incorporated into hepatocyte membranes, making it more pharmacologically active than crude lecithin at equivalent capsule counts.

### How long does it take for phosphatidylcholine to work for liver health?

In the primary NAFLD observational study (n=2,843), significant improvements in liver echogenicity were observed at 24 weeks of supplementation with polyenylphosphatidylcholine, suggesting a minimum 3–6 month treatment window is needed for measurable hepatic changes. Subjective improvements in fatigue and digestive comfort may appear earlier (within 4–8 weeks), but objective markers like liver enzymes (ALT, AST) or imaging findings require longer supplementation periods and should be monitored by a healthcare provider.

### What is the recommended dosage of PhosChol for ulcerative colitis?

The Phase 2 RCT that demonstrated steroid withdrawal in 50% of UC patients used delayed-release phosphatidylcholine at a dose of approximately 0.5–4 g/day titrated over the trial period, with the delayed-release formulation specifically designed to deliver PC to the distal colon where the mucus PC deficit is most pronounced in UC. Standard PhosChol concentrate (non-delayed-release) may not replicate these results as effectively, since colonic delivery is critical for the mechanism of action; individuals with UC should consult a gastroenterologist before initiating supplementation.

### Does phosphatidylcholine raise TMAO levels and increase heart disease risk?

Phosphatidylcholine is a substrate for gut bacterial TMA lyases, which cleave the choline head group to produce trimethylamine (TMA); TMA is then oxidized in the liver by FMO3 to TMAO, a metabolite epidemiologically linked to atherosclerosis risk. However, the clinical significance depends heavily on individual microbiome composition — people with low abundances of TMA-producing bacteria (e.g., certain Clostridiales species) generate substantially less TMAO from equivalent PC doses. Current evidence does not establish that PC supplementation causes cardiovascular events, but individuals with existing cardiovascular disease or known gut dysbiosis may wish to monitor TMAO levels with their physician.

### Can PhosChol be taken with other liver supplements like milk thistle or NAC?

PhosChol is generally compatible with common hepatoprotective agents including silymarin (milk thistle), N-acetylcysteine (NAC), and alpha-lipoic acid, as these compounds act via complementary mechanisms — silymarin inhibits hepatic stellate cell activation and scavenges reactive oxygen species, NAC replenishes glutathione, and PC restores membrane phospholipid composition and supports VLDL lipid export. No pharmacokinetic drug-drug interactions between PC and these nutraceuticals have been identified in the literature, though stacking multiple liver supplements should ideally be guided by a hepatologist, particularly in patients with diagnosed liver disease who may also be taking prescription medications like statins or metformin that have their own hepatic metabolism considerations.

### Is PhosChol safe to take during pregnancy and breastfeeding?

PhosChol is derived from phosphatidylcholine, which is a natural component of cell membranes found in foods like eggs and soy, suggesting a favorable safety profile during pregnancy. However, clinical safety data specific to pregnancy and breastfeeding is limited, so it is essential to consult with a healthcare provider before use during these periods. Most prenatal care providers consider dietary sources of phosphatidylcholine safe, but supplemental doses should be individually assessed.

### Does PhosChol interact with corticosteroids or immunosuppressant medications?

PhosChol may have complementary rather than antagonistic effects with corticosteroids in ulcerative colitis, as clinical trials showed patients taking PhosChol achieved steroid withdrawal more frequently than placebo controls. However, no major direct drug interactions with corticosteroids or immunosuppressants have been documented in the literature. Given PhosChol's potential to support gut barrier function, patients taking these medications should inform their prescriber before starting supplementation to allow proper monitoring.

### What is the clinical evidence strength for PhosChol compared to other gut barrier supplements like L-glutamine or bone broth?

PhosChol has Phase 2 randomized controlled trial evidence specifically for ulcerative colitis with a 50% steroid withdrawal rate versus 10% for placebo, representing moderate-quality evidence for this indication. In contrast, L-glutamine and bone broth have primarily observational or preliminary evidence for gut barrier support without similarly rigorous RCT data. PhosChol's mechanism of integrating directly into intestinal mucus phospholipids is mechanistically distinct and more well-characterized than alternative barrier-support supplements.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*